Search - tctmd.com

Displaying 101 - 120 of 129

Sort: Relevancy | Date

Presentation TCT 2018

DANCE: Two-Year Outcomes of Adventitial Dexamethasone Delivery During Femoropopliteal Revascularization

Presenter: Lindsay S. Machan, Craig M. Walker, Ehrin J. Armstrong

September 22, 2018

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

Presentation TCT 2017

TCT 60: Stent Versus Non-Stent Strategies for Endovascular Treatment of Femoropopliteal Peripheral Artery Disease: Insights from the XLPAD Registry

Presenter: Sahil A. Parikh, Micah Steinbrecher, MD

October 31, 2017

Presentation TCT 2017

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Presenter: Tony Das, Thomas Zeller, Grzegorz Halena, MD

October 30, 2017

Presentation TCT 2017

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Presenter: Tony Das, Thomas Zeller, Georgios Bouras

October 30, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

Presentation TCT 2016

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal

Presenter: Kenneth Rosenfield, Sahil A. Parikh

October 31, 2016

Presentation TCT 2016

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Presenter: Sriram S. Iyer, Craig M. Walker, Daniel Ortiz

October 31, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

September 15, 2016

Advertisement

DANCE: Two-Year Outcomes of Adventitial Dexamethasone Delivery During Femoropopliteal Revascularization

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

TCT 60: Stent Versus Non-Stent Strategies for Endovascular Treatment of Femoropopliteal Peripheral Artery Disease: Insights from the XLPAD Registry

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content